The Effect of the Alpha-7 Nicotinic AChR Agonist GTS-21 on Inflammation and End-Organ Dysfunction During Human Endotoxemia.
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2015
At a glance
- Drugs GTS 21 (Primary) ; Escherichia coli lipopolysaccharide; Lipopolysaccharide
- Indications Alzheimer's disease; Attention-deficit hyperactivity disorder; Cognition disorders
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 04 Nov 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 04 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.